Skip to content
EntityQ5431893· pop 6· linked from 323 articles

Also known as AQ-A-39

Falipamil is a calcium channel blocker.

~2 min read

Encyclopedic overview

2 sections
Contents
  • Research
  • References

{{chembox | Verifiedfields = changed | Watchedfields = changed | verifiedrevid = 444814816 | ImageFile=Falipamil.svg | ImageSize= | PIN=2-(3-{[2-(3,4-Dimethoxyphenyl)ethyl]methylamino}propyl)-5,6-dimethoxy-2,3-dihydro-1H-isoindol-1-one | OtherNames= |Section1= |Section2= |Section3= }} Falipamil is a calcium channel blocker.

== Research == Falipamil is a bradycardic drug focused on decreasing the heart rate of animals. The drug focuses on treating sinuses in some animals, with the most common experiments being conducted in dogs. Falipamil is commonly administered to reduce sinus, and different dosage administrations have proven to bear different results When given in small doses, the drug is effective in reducing sinus rate, but when given in high doses, the drug increases the sinus rate as the drug increases the atrial pumping rate, thus increasing the amount of body fluid pumped through the body to the face. When falipamil is administered, the drug decreases the ventricular rate of the heart, which in turn helps reduce the sinus rate in an organism.

Excerpted from Wikipedia’s “falipamil” article, available under the CC BY-SA 4.0 licence.

Available in 6 languages

via Wikidata sitelinks · CC0